Becton

Novogene (SHA: 688315), a genomic services and solutions provider based in Beijing and operating globally, has entered into a strategic partnership with US medical technology giant Becton, Dickinson and Co. (BD). The collaboration focuses on the single cell instrument HT Xpress and the establishment of a joint laboratory dedicated to…